Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Actaea racemosa + Caulophyllum thalictroides is a homeopathic combination preparation developed by Boiron, consisting of ultra-diluted botanical extracts (9CH potency). Actaea racemosa (black cohosh) and Caulophyllum thalictroides (blue cohosh) are traditionally used in homeopathy to regulate uterine contractions and facilitate cervical dilation. The combination is specifically indicated for reducing the duration of the first stage of labor and managing prolonged labor. It has been evaluated in Phase 3 clinical trials in Spain, administered starting at 37 weeks of pregnancy. As a homeopathic product, it does not have a defined pharmacological target in the conventional sense.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on actaea racemosa + caulophyllum thalictroides.